Published in Aerosp Med on May 01, 1972
Microparticle enlargement and altered surface proteins after air decompression are associated with inflammatory vascular injuries. J Appl Physiol (1985) (2011) 0.87
Acute ischemic colitis during scuba diving: report of a unique case. World J Gastroenterol (2008) 0.78
We cannot afford to lose the animal rights war. CMAJ (1990) 5.73
Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol (1988) 4.16
Nitric oxide synthase activities in human myocardium. Lancet (1993) 2.72
cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci U S A (1996) 2.17
Coagulation studies in ulcerative colitis and Crohn's disease. Gastroenterology (1975) 2.08
Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med (1990) 2.05
Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation (2000) 2.01
Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol (2007) 1.88
Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res (1999) 1.78
The mechanisms of platelet dysfunction during extracorporeal membrane oxygenation in critically ill neonates. Crit Care Med (2000) 1.68
Release of gelatinase A during platelet activation mediates aggregation. Nature (1997) 1.65
Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Thorac Cardiovasc Surg (2001) 1.55
Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A (1994) 1.53
Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost (1999) 1.43
Effects of sleep deprivation and exercise on glucose tolerance. Aviat Space Environ Med (1993) 1.40
A controlled clinical trial using placebos in normal subjects: a teaching exercise. Can Med Assoc J (1967) 1.39
Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer (1994) 1.39
Involvement of platelets and microthrombi in experimental decompression sickness: similarities with disseminated intravascular coagulation. Aerosp Med (1971) 1.38
An audit of blood component therapy in a Canadian general teaching hospital. CMAJ (1989) 1.32
Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc Natl Acad Sci U S A (1994) 1.29
Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc Res (1994) 1.28
Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty. Lancet (1994) 1.20
Interactions between gas bubbles and components of the blood: implications in decompression sickness. Aerosp Med (1972) 1.20
Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ Res (2000) 1.19
Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res (2001) 1.18
Direct electrochemical measurement of nitric oxide released from human platelets. Biochem Biophys Res Commun (1993) 1.15
The formation of nitric oxide donors from peroxynitrite. Br J Pharmacol (1995) 1.14
The role of nitric oxide and metalloproteinases in the pathogenesis of hyperoxia-induced lung injury in newborn rats. Br J Pharmacol (1998) 1.12
Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. Am J Cardiol (1984) 1.09
Pulse wave velocity in patients with obesity and hypertension. Am Heart J (1986) 1.08
Localization and translocation of MMP-2 during aggregation of human platelets. Thromb Haemost (1998) 1.07
Effect of cold exposure on various sites of core temperature measurements. J Appl Physiol Respir Environ Exerc Physiol (1983) 1.06
Effects on handgrip strength due to arm immersion in a 10 degree C water bath. Aviat Space Environ Med (1978) 1.06
Intraventricular haemorrhage and haemostasis defects. Arch Dis Child (1984) 1.00
Sleep deprivation and the effect on exercise performance. Sports Med (1989) 1.00
Inhibition of matrix metalloproteinase MMP-2 activates chloride current in human airway epithelial cells. Can J Physiol Pharmacol (1999) 0.99
The ultrastructural morphology of air embolism: platelet adhesion to the interface and endothelial damage. Br J Exp Pathol (1973) 0.98
Effect of melarsoprol treatment on circulating IL-10 and TNF-alpha levels in human African trypanosomiasis. Clin Immunol Immunopathol (1997) 0.98
Assessment of differences between repeated pulse wave velocity measurements in terms of 'bias' in the extrapolated cardiovascular risk and the classification of aortic stiffness: is a single PWV measurement enough? J Hum Hypertens (2011) 0.98
Comparison of some effects of dipyridamole and adenosine on thrombus formation, platelet adhesiveness and blood pressure in rabbits and rats. Nature (1968) 0.97
Polarized release of matrix metalloproteinase-2 and -9 from cultured human placental syncytiotrophoblasts. Biol Reprod (2000) 0.95
Effect of ibuprofen on platelet function in normal subjects and hemophiliac patients. Clin Pharmacol Ther (1978) 0.95
Changes in blood lipid concentration and cell counts following decompression sickness in rats and the influence of dietary lipid. Can J Physiol Pharmacol (1967) 0.94
Nitric oxide activates chloride currents in human lung epithelial cells. Am J Physiol (1997) 0.94
Effect of three nonsteroidal anti-inflammatory agents on platelet function and prostaglandin synthesis in vitro. Thromb Res (1978) 0.93
Differential release of matrix metalloproteinase-9 and nitric oxide following infusion of endotoxin to human volunteers. Acta Anaesthesiol Scand (2003) 0.93
Response of lipoprotein lipase in various tissues to cold exposure. Am J Physiol (1971) 0.93
Portal venous gas (PVG) as an indication for heparinization. Am J Surg (1972) 0.92
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. Br J Pharmacol (2011) 0.92
Contribution of exertional hyperthermia to sympathoadrenal-mediated lymphocyte subset redistribution. J Appl Physiol (1985) (1999) 0.91
The effects of stress on homeostasis in JCR-LA-cp rats: the role of nitric oxide. J Pharmacol Exp Ther (1998) 0.91
Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin. Br J Pharmacol (2001) 0.91
Comparative pharmacology of analogues of S-nitroso-N-acetyl-DL-penicillamine on human platelets. Br J Pharmacol (1994) 0.91
Pharmacological characteristics of solid-phase von Willebrand factor in human platelets. Br J Pharmacol (2001) 0.90
A review of blood changes associated with compression-decompression: relationship to decompression sickness. Undersea Biomed Res (1974) 0.90
Platelets increase survival of adenocarcinoma cells challenged with anticancer drugs: mechanisms and implications for chemoresistance. Br J Pharmacol (2012) 0.89
Effects of adenosine analogues and of heparin on platelet thrombi in non-lipaemic and lipaemic rats. Br J Exp Pathol (1965) 0.89
Strenuous exercise and immunological changes: a multiple-time-point analysis of leukocyte subsets, CD4/CD8 ratio, immunoglobulin production and NK cell response. Int J Sports Med (1995) 0.89
Inhaled nitric oxide and inhibition of platelet aggregation in critically ill neonates. Lancet (1998) 0.88
Constitutive and inducible nitric oxide synthases in human megakaryoblastic cells. J Pharmacol Exp Ther (1992) 0.87
Development of "sports anemia" in physically fit men after daily sustained submaximal exercise. Aviat Space Environ Med (1980) 0.87
Endurance exercise with and without a thermal clamp: effects on leukocytes and leukocyte subsets. J Appl Physiol (1985) (1996) 0.86
Induction of nitric oxide release by interferon-gamma inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J Pharmacol Exp Ther (1994) 0.86
Statins: another class of antihypertensive agents? J Hum Hypertens (2006) 0.86
Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med Sci Monit (2001) 0.86
Species-dependent inhibition of platelet aggregation by adenosine and dipyridamole: paradoxical potentiation in the rat. Thromb Diath Haemorrh (1970) 0.86
An arteriovenous malformation in pregnancy: a case report and review of the literature. Am J Obstet Gynecol (1985) 0.86
Intravascular volume, extracellular fluid volume, and total body water in obese and nonobese hypertensive patients. Am J Cardiol (1983) 0.85
Nitric oxide and the pathogenesis of heart muscle disease. Eur J Clin Invest (1995) 0.85
Cytokine induction during exertional hyperthermia is abolished by core temperature clamping: neuroendocrine regulatory mechanisms. Int J Hyperthermia (2004) 0.85
Effects of inert gas narcosis on behavior--a critical review. Undersea Biomed Res (1985) 0.84
Effect of extending G-suit coverage on cardiovascular responses to positive pressure breathing. Aviat Space Environ Med (1993) 0.84
Effects of in vitro aspirin on blood platelets of gastrointestinal bleeders. Clin Pharmacol Ther (1974) 0.84
Porcine ventricular endocardial cells in culture express the inducible form of nitric oxide synthase. Br J Pharmacol (1993) 0.84
Myocardial calcium-independent nitric oxide synthase activity is present in dilated cardiomyopathy, myocarditis, and postpartum cardiomyopathy but not in ischaemic or valvar heart disease. Br Heart J (1995) 0.83
Vascular wall reactivity in conductance and resistance arteries: differential effects of insulin resistance. Can J Physiol Pharmacol (1998) 0.83
The effects of some salicylate analogues on human blood platelets. 1. Structure activity relationships and the inhibition of platelet aggregation. Life Sci (1974) 0.83
Dive-induced modifications in platelet kinetics in rats. Undersea Biomed Res (1977) 0.82
Role of matrix metalloproteinase-2 in thrombin-induced vasorelaxation of rat mesenteric arteries. Am J Physiol Heart Circ Physiol (2000) 0.82
Cyclic intramuscular temperature fluctuations in the human forearm during cold-water immersion. Eur J Appl Physiol Occup Physiol (1991) 0.82
Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis. J Thromb Haemost (2006) 0.82
Body composition and skin temperature variation. J Appl Physiol (1985) (1990) 0.82
Nitric oxide in the clinical arena. J Hypertens (1994) 0.82
The ion selective function of the epithelium of the membranous canal walls. Acta Otolaryngol (1968) 0.81
Experimental animal models of arterial thrombosis and the screening of platelet-inhibiting, anti-thrombotic drugs: a review. Methods Find Exp Clin Pharmacol (1979) 0.81
Effect of lithium on acute oxygen toxicity and associated changes in brain gamma-aminobutyric acid. Aerosp Med (1973) 0.81
The use and safety of Ibuprofen in the hemophiliac. Blood (1983) 0.81
Filtration of cryoprecipitate: a microscopic assessment of filter depostion. Transfusion (1979) 0.81
An ultrastructural study of stored human platelets after washing using prostacyclin. Br J Haematol (1985) 0.81
Sleep and stress in man: an approach through exercise and exposure to extreme environments. Can J Physiol Pharmacol (1998) 0.80
Rapid release of matrix metalloproteinase (MMP)-2 by thrombin in the rat aorta: modulation by protein tyrosine kinase/phosphatase. Thromb Haemost (1999) 0.80
Nitric oxide mediates the vascular actions of cytokines in septic shock. Eur J Clin Invest (1992) 0.80
A free fatty acid-free thyroxine relationship in serum. Can J Physiol Pharmacol (1968) 0.79
Antiplatelet drugs in a rat microsurgical model of arterial thrombosis. Thromb Res (1979) 0.79
Intravascular changes associated with hyperbaric decompression: Theoretical considerations using ultrasound. Aerosp Med (1973) 0.79
Rapid and sensitive determination of acetylsalicylic acid and its metabolites using reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 0.79
Respiratory heat loss during work at various ambient temperatures. Respir Physiol (1990) 0.79